SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bone Biologics Corp. – ‘S-1’ on 1/30/24

On:  Tuesday, 1/30/24, at 5:09pm ET   ·   Accession #:  1493152-24-4349   ·   File #:  333-276771

Previous ‘S-1’:  ‘S-1/A’ on 6/13/23   ·   Next:  ‘S-1/A’ on 2/23/24   ·   Latest:  ‘S-1/A’ on 2/26/24   ·   24 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/30/24  Bone Biologics Corp.              S-1                   64:9.1M                                   M2 Compliance LLC/FA

Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   2.72M 
 2: EX-4.2      Instrument Defining the Rights of Security Holders  HTML    227K 
 3: EX-4.5      Instrument Defining the Rights of Security Holders  HTML    135K 
 4: EX-4.6      Instrument Defining the Rights of Security Holders  HTML    133K 
 5: EX-4.7      Instrument Defining the Rights of Security Holders  HTML    147K 
 6: EX-10.2     Material Contract                                   HTML     87K 
 7: EX-23.1     Consent of Expert or Counsel                        HTML     18K 
 8: EX-FILING FEES  Calculation of Filing Fee Tables                HTML     27K 
14: R1          Cover                                               HTML     53K 
15: R2          Condensed Consolidated Balance Sheets               HTML     82K 
16: R3          Condensed Consolidated Balance Sheets               HTML     39K 
                (Parenthetical)                                                  
17: R4          Condensed Consolidated Statements of Operations     HTML     93K 
18: R5          Consolidated Statement of Stockholders' Equity      HTML     94K 
19: R6          Consolidated Statement of Stockholders' Equity      HTML     22K 
                (Parenthetical)                                                  
20: R7          Condensed Consolidated Statements of Cash Flows     HTML     87K 
21: R8          The Company                                         HTML     51K 
22: R9          Summary of Significant Accounting Policies          HTML    124K 
23: R10         Warrant Liability                                   HTML     52K 
24: R11         Income Taxes                                        HTML     75K 
25: R12         Stockholders? Equity                                HTML     58K 
26: R13         Common Stock Warrants                               HTML     91K 
27: R14         Stock-based Compensation                            HTML    197K 
28: R15         Commitments and Contingencies                       HTML     99K 
29: R16         Subsequent Events                                   HTML     47K 
30: R17         Summary of Significant Accounting Policies          HTML    152K 
                (Policies)                                                       
31: R18         Summary of Significant Accounting Policies          HTML     77K 
                (Tables)                                                         
32: R19         Warrant Liability (Tables)                          HTML     46K 
33: R20         Income Taxes (Tables)                               HTML     71K 
34: R21         Common Stock Warrants (Tables)                      HTML     88K 
35: R22         Stock-based Compensation (Tables)                   HTML    175K 
36: R23         The Company (Details Narrative)                     HTML     64K 
37: R24         Schedule of Fair Value Liabilities Measured On      HTML     32K 
                Recurring Basis (Details)                                        
38: R25         Schedule of Warrant Liability Measured Fair Value   HTML     27K 
                On A Recurring Basis Using Unobservable (Details)                
39: R26         Schedule of Antidilutive Securities Excluded from   HTML     27K 
                Computation of Earnings Per Share (Details)                      
40: R27         Summary of Significant Accounting Policies          HTML     28K 
                (Details Narrative)                                              
41: R28         Schedule of Warrant Liability Black-Scholes Model   HTML     40K 
                (Details)                                                        
42: R29         Schedule of Provision for Income Taxes (Details)    HTML     39K 
43: R30         Schedule of Deferred Tax Assets and Liabilities     HTML     34K 
                (Details)                                                        
44: R31         Schedule of Income Tax Effective Tax Rate           HTML     36K 
                (Details)                                                        
45: R32         Income Taxes (Details Narrative)                    HTML     26K 
46: R33         Stockholders? Equity (Details Narrative)            HTML    130K 
47: R34         Schedule of Warrant Activity (Details)              HTML     48K 
48: R35         Schedule of Outstanding Vested and Unexercised      HTML     51K 
                Common Stock Warrants (Details)                                  
49: R36         Common Stock Warrants (Details Narrative)           HTML     25K 
50: R37         Schedule of Stock Option Activity (Details)         HTML     60K 
51: R38         Schedule of Outstanding Stock Options (Details)     HTML     84K 
52: R39         Schedule of Assumptions Using Black-Scholes Option  HTML     43K 
                Pricing Model (Details)                                          
53: R40         Stock-based Compensation (Details Narrative)        HTML     54K 
54: R41         Commitments and Contingencies (Details Narrative)   HTML    103K 
55: R42         Schedule of Fair Value Liabilities Measured on      HTML     32K 
                Recurring Basic (Details)                                        
56: R43         Schedule of Warrant Liability Measured Fair Value   HTML     25K 
                on a Recurring Basic Using Unobservable (Details)                
57: R44         Schedule of Anti Dilutive Securities Excluded from  HTML     27K 
                Computation of Earnings Per Share (Details)                      
58: R45         Schedule of Assumptions Using Black-Scholes Option  HTML     28K 
                Pricing Mode (Details)                                           
59: R46         Subsequent Events (Details Narrative)               HTML    113K 
61: XML         IDEA XML File -- Filing Summary                      XML    105K 
64: XML         XBRL Instance -- forms-1_htm                         XML   1.91M 
60: EXCEL       IDEA Workbook of Financial Report Info              XLSX    126K 
10: EX-101.CAL  XBRL Calculations -- bblg-20230930_cal               XML    101K 
11: EX-101.DEF  XBRL Definitions -- bblg-20230930_def                XML    493K 
12: EX-101.LAB  XBRL Labels -- bblg-20230930_lab                     XML    906K 
13: EX-101.PRE  XBRL Presentations -- bblg-20230930_pre              XML    692K 
 9: EX-101.SCH  XBRL Schema -- bblg-20230930                         XSD    139K 
62: JSON        XBRL Instance as JSON Data -- MetaLinks              335±   489K 
63: ZIP         XBRL Zipped Folder -- 0001493152-24-004349-xbrl      Zip    592K 




        
Filing Submission 0001493152-24-004349 – SGML Text

Original SGML Text submitted by:  M2 Compliance LLC/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 11:30:31.4am ET